2篇
您的检索式：作者名="Tim R.Fenton"
|
|
|
题名
|
作者
|
年代
|
出处
|
被引量
|
| 1 | What really matters-response and resistance in cancer therapy显示文摘From 10th to 12th September of 2018,we held the first British Association of Cancer Research(BACR)Special Conference on“Response and Resistance in Cancer Therapy”at the University of Kent,Canterbury,UK.The conference theme is the subject of this Special Issue of Cancer Drug Resistance and we hope this editorial and the following contributions,will give you an insight into this important topic. | Tim R.Fenton Michelle D.Garrett Mark N.Wass Martin Michaelis | 2018 | Cancer Drug Resistance2018，1，4： | 0 |
| 2 | Meeting Abstracts of the BACR conference:response and resistance in cancer therapy显示文摘1.Targeting chemoresistance induced by MYCN and ALK in neuroblastoma Louis Chesler Institute of Cancer Research,London,UK Neuroblastoma,a tumour of peripheral nerve,is the most common solid tumour of young children and in high-risk diseases,which comprises approximately half of patients,and the death from chemoresistant,metastatic relapse is very frequent. | Tim R.Fenton Michelle D.Garrett Martin Michaelis Mark N.Wass | 2018 | Cancer Drug Resistance2018，1，4： | 0 |
您所在的机构暂未开通此部分的功能，请联系管理员